| Name | Title | Contact Details |
|---|
Kennesaw State University is a comprehensive university recognized for its entrepreneurial spirit, global engagement and sense of community. As Georgia`s third-largest university and one of the fifty largest public universities in the country, Kennesaw State offers more than 100 undergraduate and graduate degrees, including an increasing number of doctoral programs. Kennesaw State is committed to becoming a world-class academic institution positioned to broaden its academic and research missions and expand its scope on a local, national and global level.
The Catholic University of America, founded in 1887 by the U.S. Catholic bishops with the support of Pope Leo XIII, is the national university of the Catholic Church in the United States. Established as a graduate research center, the University began offering undergraduate education in 1904 and today is home to 12 schools and 21 research facilities. Catholic University is the only American university with ecclesiastical faculties granting canonical degrees in three disciplines. The University`s verdant 180-acre campus, located just north of Capitol Hill, allows students easy access to the wide range of educational, cultural, and political opportunities that Washington, D.C. has to offer.
Western Technical College is a El Paso, TX-based company in the Education sector.
Hudson Valley Community College is a public community college in Troy, New York. It is associated with the State University of New York. Although about eighty percent of the students are from the local area, the remainder are from other parts of New York, other states and from some 30 countries around the world.
HistoSonics Inc. is a new medical device company that is developing Histotripsy, a non-invasive image guided and robotic tissue excision technology that was licensed from the University of Michigan. Histotripsy is a versatile platform that will replace traditional surgical and minimally invasive methods to reduce patient trauma and health care costs. The first clinical application will be treatment of Benign Prostatic Hyperplasia (BPH), a prevalent condition in senior men. The condition affects over two million men in the US and approximately 400,000 are treated surgically each year.